We have located links that may give you full text access.
Journal Article
Review
N6-methyladenine RNA Methylation Epigenetic Modification and Kidney Diseases.
KI Reports 2023 January
RNA methylation modification is a rapidly developing field in epigenetics. N6-methyladensine (m6 A) is the most common internal modification in eukaryotic mRNA. m6 A group regulates RNA splicing, stability, translocation, and translation. Enzymes catalyzing this process were termed as writers, erasers, and readers. Recent studies have focused on exploring the role of RNA methylation in human diseases. RNA methylation modifications, particularly m6 A, play important roles in the pathogenesis of kidney diseases. In this review, we provide a brief description of m6 A and summarize the impact of m6 A on acute and chronic kidney disease (CKD) and possible future study directions for this research.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app